UroGen Pharma Ltd. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
UroGen Pharma Ltd. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q3 2024.
  • UroGen Pharma Ltd. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $1.05M, a 44.8% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $1.05M -$853K -44.8% Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $1.25M -$857K -40.7% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $1.44M -$886K -38% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $1.67M -$781K -31.9% Dec 31, 2023 10-Q 2024-11-06
Q3 2023 $1.91M -$761K -28.5% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $2.11M -$9K -0.43% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $2.33M +$1.38M +146% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $2.45M +$1.27M +108% Dec 31, 2022 10-K 2024-03-14
Q3 2022 $2.67M +$1.25M +88% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $2.12M +$463K +28% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $945K -$235K -19.9% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $1.18M -$978K -45.3% Dec 31, 2021 10-K 2023-03-24
Q3 2021 $1.42M -$1.23M -46.5% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $1.65M -$1.36M -45.1% Jun 30, 2021 10-Q 2021-08-04
Q1 2021 $1.18M -$2.25M -65.6% Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $2.16M -$1.58M -42.2% Dec 31, 2020 10-K 2022-03-21
Q3 2020 $2.65M +$229K +9.45% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $3.01M +$454K +17.8% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $3.43M +$656K +23.6% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $3.74M +$713K +23.6% Dec 31, 2019 10-K 2021-03-18
Q3 2019 $2.42M Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $2.56M Jun 30, 2019 10-Q 2019-08-09
Q1 2019 $2.78M Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $3.02M Jan 1, 2019 10-K 2020-03-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.